default author photo

Gang Chen

Huazhong University of Science and Technology (Formerly Tongi Medical University) - National Clinical Research Center for Gynecology and Obstetrics

1239 Siping Road

Shanghai, 200092

China

Huazhong University of Science and Technology

SCHOLARLY PAPERS

3

DOWNLOADS

208

TOTAL CITATIONS

2

Scholarly Papers (3)

1.

SARS-CoV-2 Viral Dynamic Shedding, Seroconversion, and Diseases Severity Among 3192 Patients Hospitalized with COVID-19: A Large Case Series Study in Wuhan

Number of pages: 21 Posted: 11 Jun 2020
Huazhong University of Science and Technology (Formerly Tongi Medical University) - National Clinical Research Center for Gynecology and Obstetrics, Hainan Medical University - Key Laboratory of Tropical Translational Medicine of Ministry of Education, Huazhong University of Science and Technology (Formerly Tongi Medical University) - National Clinical Research Center for Gynecology and Obstetrics, Huazhong University of Science and Technology (Formerly Tongi Medical University) - National Clinical Research Center for Gynecology and Obstetrics, Huazhong University of Science and Technology (Formerly Tongi Medical University) - National Clinical Research Center for Gynecology and Obstetrics, Huazhong University of Science and Technology (Formerly Tongi Medical University) - National Clinical Research Center for Gynecology and Obstetrics, Huazhong University of Science and Technology (Formerly Tongi Medical University) - National Clinical Research Center for Gynecology and Obstetrics, Huazhong University of Science and Technology (Formerly Tongi Medical University) - National Clinical Research Center for Gynecology and Obstetrics, Huazhong University of Science and Technology (Formerly Tongi Medical University) - National Clinical Research Center for Gynecology and Obstetrics, Huazhong University of Science and Technology (Formerly Tongi Medical University) - National Clinical Research Center for Gynecology and Obstetrics, Huazhong University of Science and Technology (Formerly Tongi Medical University) - National Clinical Research Center for Gynecology and Obstetrics, Huazhong University of Science and Technology (Formerly Tongi Medical University) - National Clinical Research Center for Gynecology and Obstetrics, Huazhong University of Science and Technology (Formerly Tongi Medical University) - National Clinical Research Center for Gynecology and Obstetrics, Huazhong University of Science and Technology (Formerly Tongi Medical University) - National Clinical Research Center for Gynecology and Obstetrics, Huazhong University of Science and Technology (Formerly Tongi Medical University) - National Clinical Research Center for Gynecology and Obstetrics, Huazhong University of Science and Technology (Formerly Tongi Medical University) - National Clinical Research Center for Gynecology and Obstetrics, Huazhong University of Science and Technology (Formerly Tongi Medical University) - National Clinical Research Center for Gynecology and Obstetrics, Huazhong University of Science and Technology - Cancer Biology Research Center, Huazhong University of Science and Technology (Formerly Tongi Medical University) - National Clinical Research Center for Gynecology and Obstetrics, Huazhong University of Science and Technology - Department of Obstetrics and Gynecology and Huazhong University of Science and Technology (Formerly Tongi Medical University) - National Clinical Research Center for Gynecology and Obstetrics
Downloads 92 (736,406)
Citation 2

Abstract:

Loading...

COVID-19; viral shedding; seroconversion; convalescent plasmas

2.

Trends and Age-Period-Cohort Effects on Mortality of the Three Major Gynecologic Cancers in China from 1990 to 2019: Cervical, Ovarian and Uterine Cancer

Number of pages: 18 Posted: 27 May 2021
Huazhong University of Science and Technology - Tongji Hospital, Huazhong University of Science and Technology (Formerly Tongi Medical University) - National Clinical Research Center for Gynecology and Obstetrics, Huazhong University of Science and Technology (Formerly Tongi Medical University) - National Clinical Research Center for Gynecology and Obstetrics, Huazhong University of Science and Technology (Formerly Tongi Medical University) - National Clinical Research Center for Gynecology and Obstetrics, Huazhong University of Science and Technology (Formerly Tongi Medical University) - National Clinical Research Center for Gynecology and Obstetrics, Huazhong University of Science and Technology - Cancer Biology Research Center and Huazhong University of Science and Technology (Formerly Tongi Medical University) - National Clinical Research Center for Gynecology and Obstetrics
Downloads 77 (837,727)

Abstract:

Loading...

mortality trend; cervical cancer; ovarian cancer; uterine cancer; China

3.

Neoadjuvant Niraparib Monotherapy for Newly Diagnosed Unresectable HRD-Positive High-Grade Serous Ovarian Cancer (NANT): A Multicenter, Prospective, Phase 2 Trial

Number of pages: 31 Posted: 09 Feb 2026
Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Sichuan University, Sun Yat-sen University (SYSU), Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology - Department of Radiology, Huazhong University of Science and Technology, Huazhong University of Science and Technology (Formerly Tongi Medical University) - National Clinical Research Center for Gynecology and Obstetrics, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Shandong University, Wuhan University, Sichuan University, Sichuan University, Sichuan University, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, University of California, San Francisco (UCSF), Zai Lab (Shanghai) Co, Ltd., Precision Scientific (Beijing) Co., Ltd., Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Huazhong University of Science and Technology, Guangdong Academy of Medical Sciences, Huazhong University of Science and Technology - Hubei Cancer Hospital, Independent, Shandong University, Wuhan University - Department of Gynecology and Obstetrics, Huazhong University of Science and Technology - Department of Obstetrics and Gynecology, Huazhong University of Science and Technology and Huazhong University of Science and Technology - Cancer Biology Research Center
Downloads 39 (1,263,436)

Abstract:

Loading...

Ovarian cancer, neoadjuvant therapy, PARP inhibitor, homologous recombination deficiency